On the Register
Login

Why the Mounjaro price went up in the UK

From September 2025 the maker raised the UK list price of Mounjaro. That is the wholesale price pharmacies pay, which is why private prices rose and the NHS charge did not. Here is what changed and what it means for you.

Last updated

The short version

  • Eli Lilly raised the UK list price of Mounjaro from 1 September 2025, confirmed in mid-August 2025.
  • The list price is what pharmacies pay, not the price you pay at a clinic. Private prices rose and vary by provider.
  • NHS reimbursement was re-set to match; NHS patients still pay the standard prescription charge or nothing if exempt.
  • Lilly said it was to bring the UK in line with other developed countries, where its price had been much lower.

What actually changed

In mid-August 2025 Lilly confirmed it would raise the UK list price of Mounjaro, effective from 1 September 2025. The company said the increase was intended to address pricing inconsistencies compared with other developed countries, including in Europe: the UK list price had been set well below the price in many other markets. The list prices went up across the dose strengths.

List price is not the price you pay

This is the part that causes confusion. The list price is what the manufacturer charges a pharmacy for the medicine. When you buy privately, the provider adds its own margin and, almost always, a consultation or assessment fee, so the figure you are quoted is higher than the list price and differs from one provider to the next. A higher list price pushes those private prices up, but it does not set them.

Why the NHS charge did not change

For NHS prescriptions, the Department of Health and Social Care re-determined the reimbursement prices from September 2025 so they reflect the new, higher list prices, which keeps pharmacies from dispensing at a loss. What you pay as an NHS patient did not change: it is the standard prescription charge per item, or nothing if you are exempt. So the increase is felt mainly by private patients.

If your price jumped

A sudden change can be a price rise, or it can be a supply problem dressed up as one. Either way the safe moves are the same:

Common questions

Why did Mounjaro get more expensive?
The maker, Eli Lilly, raised the UK list price of Mounjaro from 1 September 2025, confirmed in mid-August 2025. Lilly said it was to address pricing inconsistencies compared with other developed countries, including in Europe, where the UK list price had been much lower. The change mainly affects private patients.
What is the “list price”, and is it what I pay?
The list price is what Lilly charges pharmacies for the medicine, not the price you pay at a private clinic. Each provider adds its own margin and usually a consultation or assessment fee, so the price you see is higher and varies between providers.
Did it change NHS prescriptions?
The NHS reimbursement prices were re-determined from September 2025 to match the higher list prices, so pharmacies are not dispensing at a loss. If you get Mounjaro on the NHS you still pay the standard prescription charge, or nothing if you are exempt. The rise is felt mainly in the private market.
Why do private prices differ so much between pharmacies?
Because each provider sets its own retail price on top of the wholesale list price, and may charge a separate consultation fee. After the list price rose, some providers passed it on and a few temporarily froze their prices. Always check the current price with the provider.
My price jumped. What should I do?
Check whether it is a national shortage or a price change, compare registered providers, and keep continuity of care. Never switch to an unlicensed seller to save money. See the guide on what to do if your pharmacy runs out or the price jumps.

Sources

Prices are reported, not promoted, and change over time. Figures and dates are as of 3 November 2026. This is factual reference, not medical advice.